- Home
- AESI vs PVLA Comparison
AESI vs PVLA Comparison
Compare AESI & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AESI | PVLA |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | AESI | PVLA |
|---|---|---|
| Price | $11.99 | $129.38 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 15 |
| Target Price | $11.63 | ★ $171.87 |
| AVG Volume (30 Days) | ★ 4.8M | 238.6K |
| Earning Date | 05-04-2026 | 05-14-2026 |
| Dividend Yield | ★ 4.27% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,095,310,000.00 | N/A |
| Revenue This Year | $1.43 | N/A |
| Revenue Next Year | $16.83 | $102,383.52 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.73 | N/A |
| 52 Week Low | $7.64 | $20.20 |
| 52 Week High | $14.93 | $151.18 |
Technical Indicators
Market Signals| Indicator | AESI | PVLA |
|---|---|---|
| Relative Strength Index (RSI) | 46.61 | 57.45 |
| Support Level | $10.67 | $108.99 |
| Resistance Level | $12.33 | $133.06 |
| Average True Range (ATR) | 0.81 | 8.97 |
| MACD | -0.19 | 0.55 |
| Stochastic Oscillator | 35.33 | 78.61 |
Price Performance
Historical ComparisonAbout AESI Atlas Energy Solutions Inc.
Atlas Energy Solutions Inc is a provider of proppant and logistics services to the oil and natural gas industry within the Permian Basin of West Texas and New Mexico, the active oil and natural gas basin in North America. Proppant is necessary to facilitate the recovery of hydrocarbons from oil and natural gas wells. One hundred percent of its sand reserves are located in Winkler and Ward Counties, Texas, within the Permian Basin, and its operations consist of proppant production and processing facilities, including two facilities near Kermit, Texas, and a third facility near Monahans, Texas.
About PVLA Palvella Therapeutics Inc.
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.